Apr. 24 at 2:30 AM
$KZIA $CELC Upside explanation condensed into single (longish) paragraph" The Kazia drug paxalisib is one of only 2 drugs in development in the Pi3K mTOR, MULTI isofoym ( there are 4 isoforms), drug class. The other is Celcuity. The Pi3K pathway controls human growth and function. Errant enzymes in the Pi3K pathway strongly contribute to cancer and half of other human diseases in our life. Pi3K drugs, especially single isoform Pi3K alpha isoform - that are safe, help to inhibit ( means repair) this pathway and fight cancer. Celcuity explains perfectly that only 4 isoforms Pi3K mTOR drugs eg Kazia & Celcuity are highly more effective, than Pi3K alpha alone. Only paxalisib enters the brain - head to head with Celcuity, will be of much interest, at a later time. So apparent huge potential here, with this company. " Both companies, in fact.
